16 results on '"Do, Kim-Anh"'
Search Results
2. Downregulation of UBA1 in Myelodysplastic Syndrome
3. Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)
4. Transcriptomic Signitures of Azacitidine (AZA) and Decitabine (DAC) Resistance in MDS and CMML
5. Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
6. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
7. Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis
8. Impact of Hemoglobin Level As a Continuous Variable in Calculating Prognosis in MDS: Incorporation into LSC4 and IPSS-R
9. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia
10. Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance
11. Evolutionary Action (EA) Score of TP53 Mutations Defines Prognostic Subsets within TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
12. Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes
13. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
14. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
15. The Effect of Initial Therapy Choice in Determining Long Term Survival in Patients with Chronic Lymphocytic Leukemia (CLL).
16. Evolutionary Action (EA) Score of TP53Mutations Defines Prognostic Subsets within TP53Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.